chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had her 1st vaccine on 15Mar2021(confirmed) , she had a positive test on 29th; had her 1st vaccine on 15Mar2021(confirmed) , she had a positive test on 29th; This is a spontaneous report from a contactable consumer (parent). A 17-years-old female patient (Reporter's daughter) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 15Mar2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient received her 1st Pfizer vaccine on 08Mar2021 and ended up getting a positive Covid test on 26Mar2021 and the test came back positive and then it was clarified that she got a positive test (Covid-19 test) on 29th (29Mar2021), she had her 1st vaccine on 15Mar2021(confirmed). The CVC called her and told her that she could have her 2nd vaccine on 09Apr2021 as long as she has no more symptoms, she got her 2nd vaccine on 12Apr2021, after the 1st vaccine she had no reaction. The result was on 31st but she got the test on 29th. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Patient presented to ED on 3/27/21 with 3 day history of weakness and diarrhea.  COVID test was positive following 1st COVID vaccination.  Patient diagnosed with diverticulitis with secondary cystitis.  Patient was treated with antibiotics, steroids, oxygen, and remdesivir.  Patient recovered and discharge to home.
L arm was red, swollen and warm to touch. Mom stated child was scratching arm a lot. Area still red, slightly swollen and very warm to touch today. (6/10/10).
Itchy, red, swollen at vaccine site on day 8 after first vaccine.  Redness is larger and more spread out on day 9 (4/25/2021)
Shingles/ Shingles rash; Rash; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 92-year-old female patient who received Herpes zoster (Shingrix) (batch number 2G2T7, expiry date 15th November 2021) for prophylaxis.   On 15th August 2019, the patient received the 1st dose of Shingrix. On 23rd August 2019, 8 days after receiving Shingrix, the patient experienced shingles and rash. On an unknown date, the outcome of the shingles and rash were not recovered/not resolved.   It was unknown if the reporter considered the shingles and rash to be related to Shingrix.  Additional details were provided as follows: The health care professional reported that, the patient experienced shingles, defined as shingles rash, 1 week after the vaccination with dose of Shingrix. The health care professional stated that, rash was not worsened or improved since it developed, it was diagnosed as shingles by primary care physician on 23rd August 2019.
Patient experienced left thigh swelling, itching and warmth 1 day after vaccines were given.
Patient stated that she had a "knot" or harden area in her left bicep. Upon palpation, it seems like a hard nodule/bump.
After the 1st does my heart rate increased however I did not check the number. At night I noticed while in bed that the bed was shaking and thought it was my husband scratching his head or my dog was moving causing the bed to shake. This happened every night and I was confused because this shaking feeling was not normal. After this same night shaking continued for three weeks I got up one night to go to the bathroom and realized I was the one shaking. During the past three weeks I was waking up frequently but was not putting everything together. Once I realized I was the one shaking I started assessing the situation but was more confused than anything. On May 10th I had my second COVID vaccine. The day afterwards I noticed I had high anxiety that was uncharacteristic for me and my heart rate was racing. I check it on my iWatch and it was 145 bpm while I was work at my computer doing nothing strenuous. My normal range is 65 bpm - 85 bpm. My sleep was restless and the shaking that had previously calmed down some increased enough for me now to realized the vaccine was the contributor of my symptoms.
PSA TEST INCREASED 0.3; This spontaneous report received from a patient concerned a 57 year old male. The patient's height, and weight were not reported. The patient's past medical history included transurethral resection of the prostate cancer, and prostate cancer, and other pre-existing medical conditions included in 2010, the patient had radiation treatment, and in 2015 chemo pills treatments, and then remission until now. They also did targeted radiation. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 180-5031) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 27-APR-2021, the subject experienced prostatic specific antigen increased (PSA) test increased 0.3. Laboratory data included: Elevated prostate specific antigen [PSA] (NR: not provided) 0.3 (Unit unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of PSA test increased 0.3 was not reported. This report was non-serious.
This spontaneous report as received from a healthcare professional, via company representative, refers to her son of unknown age. On an unspecified dates, the patient received the first three doses of GARDASIL. On 28-MAY-2015, the patient was vaccinated with the fourth dose of GARDASIL (lot #, dose, route and site of administration were not reported). No adverse experience was reported. Additional information has been requested.
pt recvd 5JAN93 & pt died of SIDS on 10JAN93; no reported sx post receiving vax;
About 8:30pm, out of blue, muscles got very rigid and stiff. Patient started shaking so bad that jaw shut and could hardly open mouth. Pt. could not stop shaking, got super cold and felt weird. By 1:30 am fever started at about 101, heart was racing/beating hard, and had shortness of breath. By the morning, fever was 102. Muscles were hurting, pt. felt nauseous and had migraine headache. Patient had doctor visit on 10/2 and doctor specified it was an allergic reaction to the flu shot. Doctor prescribed steroid Prednisone (8 days). Today, patient reports getting better but still does not feel right. She is weak, with not much of appetite, and not sleeping much yet. Patient commented that the episode was scary because it was so sudden, progressed fast and felt like she was having heart attack.
Following adminisration of influenza vax, pt exp edema & erythema @ inject site; sx lasted over 72 hrs;
2 hours after vaccination acute onset of severe rigors, "cold," sweats, nausea, vomiting, diarrhea, subjective fever
USE OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned multiple patients.  No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1802068, expiry: 25-MAY-2021) dose was not reported, administered on 25-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 25-MAY-2021, the subject experienced use of expired vaccine. The action taken with covid-19 vaccine was not applicable. The outcome of use of expired vaccine was not reported. This report was non-serious.
Small raised bump initially, became red, & inflamed to size of silver dollar. Raised area became prominent. BENADRYL treatment site improved later in day.
Patient developed a warm rash on the back of her vaccinated arm 2 days after vaccination.
Patient had previously received Fluzone 0.25 in previous seasons without reaction. He was given Fluzone 0.5 IM on 9/5/19 and was initially noted to have some pain with refusal to bear weight on the left leg about 4 hours after the immunization was given. The following evening 9/6/19 about 29 hours after the immunization was given he was noted to have significant circumferential swelling of the left leg. There was no notable warmth or erythema concerning for cellulitis or type I sensitivity reaction, only extensive limb swelling in the same leg as the injection was given. He was able to move move and use leg well, and swelling was notably improved the following day.
Chest started hurting, like I had bronchitis on 9/17 (Friday), had my husband pound my back to try and break up the congestion. I lost my taste on Sunday. I tested positive on Tuesday. Called my Dr who told me to treat the symptoms so I took Mucinex. No other real symptom. No fever, no coughing or sneezing, just tightness in chest and loss of taste/smell. - Also changed Doctors since she would not teleconference or see me. Got information from her nurse.
Patient tested positive for Covid despite receiving 3 vaccinations; Patient tested positive for Covid despite receiving 3 vaccinations; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient received bnt162b2 (BNT162B2), administration date 03Dec2021 (Batch/Lot number: unknown) as dose 3 (booster), single, administration date 08Apr2021 (Batch/Lot number: unknown) as dose 2, single and administration date 11Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "Patient tested positive for Covid despite receiving 3 vaccinations". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
101F fever for 24 hours.  Low grade fever (99.9) for the next 24 hours.
Mother called 2/18/06. Reported child's arm, swollen, red at injection site.
2 days after vaccination developed optic neuritis, seen by eye doctor and Hospital, admitted and treated with a 3 day course of 1g MethylPREDNISolone for image negative optic neuritis
face/neck rash; face/neck hives; swelling; Wrinkled; This is a spontaneous report from a contactable consumer (the patient).     A 44-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on 10May2021 (Batch/Lot number was not reported) as single dose  for covid-19 immunisation  .  Medical history included Crohn's disease, pyoderma gangrenosum . Concomitant medications included adalimumab (HUMIRA) taken for an unspecified indication, start and stop date were not reported.  On 19Apr2021 the patient received the first dose of BNT162B2 and experienced rash and urticaria. The patient previously took remicade and experienced drug hypersensitivity.  The patient experienced face/neck rash (medically significant) on May2021 with outcome of unknown , face/neck hives  (medically significant) on May2021 with outcome of unknown , swelling  (medically significant) on May2021 with outcome of unknown , was wrinkled  (medically significant) on May2021 with outcome of unknown.  The patient underwent lab tests and procedures which included sars-cov-2 test: negative   on 07Jul2021  .   Therapeutic measures were taken as a result of face/neck rash and included unknown cream for the rash.  Course of the event. One week after I got my first vaccine show on 19Apr2021, and the day after I did my Humira injection, the left side of my face and neck broke out in a rash/hives. It was milder the first shot and resolved in about of week. The second shot I received 10May2021 and again a week later, face/neck rash/hives swelling, primarily on left side. Looks similar to a burn almost, dry and wrinkled.  The second shot made the rash significantly worse and I went to my dermatologist for some creams that helped. Now every time I take my Humira injection it reflares up. It is continuing still, however lessens in severity with each week.  Information on lot/batch number has been requested.
only time I ever got the flu was the one time a got the damn shot / Suspected vaccination failure; flu; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a 75-year-old patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, unknown after receiving Flu vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and influenza. On an unknown date, the outcome of the vaccination failure and influenza were unknown.   It was unknown if the reporter considered the vaccination failure and influenza to be related to Flu vaccine.  Additional case details were reported as follows: The patient reported case for our self. The age at vaccination was not reported. The patient received flu shot and got the flu. This case was considered as suspected vaccination failure as details regarding laboratory test confirmation and time to onset for the event was unknown at the time of reporting. The follow up was not required.
lymph node swelling; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200461453 (Pfizer).  A 37 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 10Jan2022 11:00 (Lot number: FJ1614) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1st, Date / Time: , Date: 10Apr2021, Time: 11:00, Site and Route of injection , Anatomical Site of injection: Left upper arm, Route of administration: Intramuscular, Batch/Lot number: EW0153), administration date: 10Apr2021, for Covid-19 immunization, reaction(s): "lymph node swelling under left armpit"; Bnt162b2 (Dose: 2nd, Date / Time: , Date: 01May2021, Time: 11:00, Site and Route of injection: , Anatomical Site of injection: Left upper arm, Route of administration: Intramuscular, Batch/Lot number: ER8736), administration date: 01May2021, for Covid-19 immunization, reaction(s): "lymph node swelling under left armpit". The following information was reported: LYMPHADENOPATHY (non-serious), outcome "recovered", described as "lymph node swelling". Therapeutic measures were not taken as a result of lymphadenopathy.  Additional information: Within 3-4 days of injection, lymph node swelling under left armpit occurred and lasted 3-4 days after each of the 3 injections. No other events occurred, no medical treatment was sought.  Follow-up (25Mar2022): Follow-up attempts are completed. No further information is expected.  No follow-up attempts are possible. No further information is expected.
HIB on the same date as MMR II; "the patient had an outbreak of mumps that was confirmed through blood work on May 10, 2019". "Patient received both MMR II vaccines on schedule".; This spontaneous report was received from a physician and refers to a non-pregnant 8 year old female patient. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 08-SEP-2011, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneously, in the right deltoid, for prevention of mumps measles and rubella, reported lot# 1484Z (expiration date was not reported).  On the same date, the patient, the patient also received Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) Lot# reported as UH390AA, by intramuscular route in the left thigh.  On 14-JUN-2017, the patient was vaccinated with the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneously, in the right deltoid, for prevention of mumps measles and rubella, reported lot# reported as M043309 (expiration date was not reported). On the same date, the patient was also vaccinated with  Hepatitis A Vaccine, Inactivated (VAQTA) lot# reported as M042658, by intramuscular route in the deltoid; the third dose of poliovirus vaccine inactivated by subcutaneous route in the deltoid; and the 4th dose of diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid by intramuscular route, in the deltoid.  It was reported that the patient had an outbreak of mumps that was confirmed through blood work on 10-MAY-2019 (Mumps antibody test), which result was 239 AU/mL, positive (mumps antibody test positive) and the patient was diagnosed with parotitis. The patient sought medical attention with pediatrician.  The pediatrician administered a third dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) on 24-MAY-2019, subcutaneously, in the right deltoid, for prevention of mumps measles and rubella (lot/batch # and expiration date were not reported).   At the time of reporting, the outcome of parotitis was resolved on an unknown date in 2019.The causality assessment between mumps and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was not reported.   Lot number M043309 is an invalid lot number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II)  Lot Number M042658 is an invalid lot number for Hepatitis A Vaccine, Inactivated (VAQTA)  Lot Number UH390AA is an invalid lot number for Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB)  This is one of several reports received from the same source.  All available medical records will be provided upon request.
Pain and swelling IM a6, 24hours after vaccination. No redness. Resolved during next 48 hours.
Given second dose of shingrix 50 MCG inj (IM) VL 10pk on 03/06/2020. By that evening I was nauseous had flu like symptoms, as well as a sore swollen arm. The next day I had fever, chills, headache, muscle pain, and slept all day with nightmares. Thankfully these symptoms were relieved by the following day. I had not experienced these symptoms with my first injection 6 months prior to my second.
I received the shot approximately 7:20 am.  When I first got the shot I had an itchy throat approx. ten minutes after the shot with a small hot spot at the back of my tongue.  Then at approx 4:00 pm I started feeling fatigue.  I went home from work after 5:00 pm and I ate dinner and felt very fatigue and achy.  So I went to bed and had cold chills, was achy had a rapid hard heart beat and had a head ache.  When I woke the next morning I felt like I could not get out of bed, at approximately 5:10 in the morning.  My muscles felt like they could not get me up so my husband pulled me up to my feet.  I continued to walk around the house and get ready for work.  I am at work now at 9:00 am and still feeling fatigue.   I emailed my doctor to give him information of how I am reacting and questioned him whether I should receive the second shot.
Information has been received from a medical assistant concerning a 10 year old white female with no pre-existing allergies or pertinent medical history who on 15-JAN-1998 was vaccinated into the right arm with a first dose varicella virus vaccine live (Oka/Merck) ("Lot # 1102"). There was no concomitant medication. There was no illness at the time of vaccination. On 05-DEC-2007, at 9:00, the patient developed 20-30 pox on her body. On 12 DEC 2007 that patient recovered. Additional information is not expected.
PT felt faint and lightheaded appox 5-10 minutes after vaccination. Lied down for approx 8 minutes and symptoms resolved.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021 at 11:15 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Mar-2022 at 12:44 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In March 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 65.94 and 66.02   Concomitant products were not provided.  On 03-Mar-2021 vials were moved to clinic. On 24-Feb-2021 the vaccines were moved to fridge. On 03-Mar-2021, the vial underwent the excursion. The vaccine beyond use date was reported as 26-Mar-2021.  On 31-Mar-2021 vials were moved to clinic. On 30-Mar-2021 the vaccines were moved to fridge. On 31-Mar-2021, the vial underwent the excursion on the following timings: at 09 AM temperature was 32. The vaccine beyond use date was reported as 29-Apr-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  The vial was not in a frozen state at the time of vaccine administration. It was reported that, the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The health care professional explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34- or 35-degree Fahrenheit.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
I was tested positive for Covid 19; I started off with a cough and sore throat then it went to having body aches and headache; I had chills but no fever I was very tired.
her throat would be sore; tongue started tingling; stinging in her tongue, like she had burned it; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (age 75; unit: unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL3248), via an unspecified route of administration on 11Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose on Monday 11Jan2021, and her tongue started tingling the next day (12Jan2021) and was continuing at the time of report. On Tuesday (12Jan2021), she started stinging in her tongue, like she had burned it. She can eat and swallow, it's just that her tongue was stinging. And sometimes her throat would be sore but it's still here. The patient was wondering if the side effect last that long or there may be some more concern. Outcome of the events was not recovered.